《CVS Dismantling Healthcare Empire: Regulatory Tailwinds v. Cost Headwinds》
AI 摘要 · CVS的分拆(不早于2028年)并不能证明其整合战略失败:零售药房已提升份额并恢复健康增长,此举是对PBM透明度要求和田纳西州所有权规则的回应。但12%的跌幅反映的是分部加总估值逻辑——零售同行估值为7至8倍EBITDA,而保险公司为11.5至12.5倍——以及新增的双重上市成本;独立估值是关键。除非国会采取行动,垂直整合很可能继续。
CVS花了多年时间打造出这个综合医疗保健巨头,结果现在在战略评估中却说:“我们要拆分成两家上市公司。”这是否等于承认它没有像他们期望的那样成功,管理层也没有实现外界对它的预期?
I mean, CVS spent years building this integrated healthcare giant , only to come along now as part of its strategic evaluation and say, "We're going to split into two publicly traded companies ."
Is this an admission that it did not succeed as they wanted, and that the administration did not achieve what was expected of it ?